INV-144 Versus Losartan in Hypertension and Type 2 Diabetes Mellitus Patients With Macroalbuminuria
Public ClinicalTrials.gov record NCT01398423. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12 Week, Phase II Trial of the Safety, Pharmacokinetics, and Efficacy of INV-144 Compared With Losartan Potassium in Patients With Hypertension and Type 2 Diabetes Mellitus With Nephropathy
Study identification
- NCT ID
- NCT01398423
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- InVasc Therapeutics, Inc.
- Industry
- Enrollment
- 88 participants
Conditions and interventions
Conditions
Interventions
- Active Control Drug
- INV-144 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2011
- Primary completion
- Jun 30, 2012
- Completion
- Jun 30, 2012
- Last update posted
- Aug 6, 2012
2011 – 2012
United States locations
- U.S. sites
- 19
- U.S. states
- 9
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Garden Grove | California | 92844 | — |
| Not listed | La Mesa | California | 91942 | — |
| Not listed | Northridge | California | 91324 | — |
| Not listed | Riverside | California | 92505 | — |
| Not listed | Tustin | California | 92780 | — |
| Not listed | Kissimmee | Florida | 34741 | — |
| Not listed | Miami | Florida | 33015 | — |
| Not listed | Macon | Georgia | 31217 | — |
| Not listed | Tucker | Georgia | 30084 | — |
| Not listed | Reisterstown | Maryland | 21136 | — |
| Not listed | Brooklyn Center | Minnesota | 55430 | — |
| Not listed | Cary | North Carolina | 27511 | — |
| Not listed | Greenville | North Carolina | 27834 | — |
| Not listed | New Bern | North Carolina | 28562 | — |
| Not listed | Raleigh | North Carolina | 27610 | — |
| Not listed | Aiken | South Carolina | 29801 | — |
| Not listed | San Antonio | Texas | 78215 | — |
| Not listed | San Antonio | Texas | 78228 | — |
| Not listed | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01398423, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 6, 2012 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01398423 live on ClinicalTrials.gov.